-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

701. Experimental Transplantation: Basic and Translational: Poster III

Symposia: Experimental Transplantation: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Gabriele Casirati, MD, PhD1, Adele Mucci, PhD2*, Marta Freschi, MSc3*, Andrea Cosentino, MD3*, Mohammed S Mahmoud, PhD4*, Jing Zeng, MD2, Nola Neri2*, Christian Brendel, PhD2*, Daniel Bauer5 and Pietro Genovese, PhD6

1Hematology Oncology, Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA
2Hematology/Oncology, Boston Children's Hospital, Boston, MA
3Boston Children Hospital, Boston, MA
4Fayoum University, Department of Zoology, College of Science, Fayoum, Egypt
5Harvard University, Boston, MA
6Boston Children's Hospital, Boston, MA

Jihoon Lee1*, Amitej Venapally, BS2*, Ruri Maekawa, BS2*, Shuichi Takayama, PhD2* and Kirsten M. Williams, MD3

1David Geffen School of Medicine, Los Angeles, CA
2Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology & Emory University School of Medicine, Atlanta, GA
3Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA

Ying WANG1*, Qingrong Huang2*, Ruqayyah sanders-Braggs3*, Yan Zhou, MS4*, Robert Hooper5*, Yuanyuan Tian, PhD6*, Tatiana Kent, PhD7*, Richard Pomerantz, PhD7*, Gennaro Clando8*, Jean-Pierre Issa8*, Jonathan Soboloff9* and Yi Zhang, MD, PhD6

1Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ
2Clinical Immunology Core, Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ
3Center for Discovery and Innovation, Hackensack University Medical Center, Nutley
4Fox Chase Cancer Center, Temple University, Philadelphia
5Temple University, Philadelphia, PA
6Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ
7Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
8Coriell Institute for Medical Research, Camden, NJ
9Temple University School of Medicine, Philadelphia, PA

Courtney Mercadante, PhD1*, Vemika Chandra, PhD1*, Miriama Kruta Vincent2*, Herika Fernandez2*, Jinpeng Wang3*, Brian Zifcak3*, Kayla Frank1*, Robert T. Peters, PhD1, Joe Salas, PhD1 and Pauline Rimmele, PhD1

1Ensoma, Inc., Boston, MA
2Ensoma, Boston, MA
3Ensoma, Inc., Boston

Albert C Yeh, MD1, Tanya Cunningham2*, Saranya R. Chakka3*, R Graeme Black3*, Kate A. Markey, MBBS, PhD, FRACP, MPH3 and Marie Bleakley, PhD, MBBS, MMSc4

1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
2Fred Hutchinson Cancer Research Center, Seattle, WA
3Fred Hutchinson Cancer Center, Seattle, WA
4Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA

Takeshi Fujino1*, Noa Avni2*, Neta Kutner2*, Hanan Khoury2*, Gat Pozner2*, Niv Sabath2*, Cynthia Castro3*, Nina Fox3*, Alexander M. Lewis4*, Steven Tittley3*, Oren Ziv2*, Yishai Ofran, MD5, Tina Napso2*, Natalie Yivgi Ohana, PhD2*, Noa Sher, PhD2* and Omar Abdel-Wahab, MD6

1Memorial Sloan Kettering Cancer Center, New York, NY
2Minovia Therapeutics, Tirat Carmel, Israel
3Memorial Sloan Kettering Cancer Center, New York
4Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
5Hematology and Stem Cell Transplantation Department, Sharee Zedek Medical Center, Jerusalem, Jerusalem, Israel
6Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Ding Yiyang, BS*, Ming Zhao, MD*, Xiang Wang, MD*, Juan Xie, MD, PhD*, Qian-Nan Shang, MD, PhD*, Xun-Hong Cao, MD, PhD*, Xiaohui Zhang, Xiao-Jun Huang, MD, PhD and Xiangyu Zhao, MD, PhD

Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Brandon Vu, BS1*, Travis Roeder, BA1, Jitendra K. Kanaujiya, PhD1*, Amy Kimble1*, Eddy Tsang1*, Jeffrey McDonald, PhD2* and Hideyuki Oguro, PhD3

1University of Connecticut School of Medicine, Farmington, CT
2University of Texas Southwestern Medical Center, Dallas, TX
3University of Connecticut Health Center, Farmington, CT

Alexander Link, PhD1*, Teresa Maria Frasconi, PhD2*, Stephan Wullschleger, PhD2*, Natalia Venetz, PhD2*, Alison Ribeiro, PhD2*, Anja Schlegel, PhD2*, Yvonne Kaufmann2*, Alienor Auge2*, Waleed Ali2*, Norbert Fic2*, Zoya Siddiqui2*, Aline Eggenschwiler2*, Sarah Jetzer2*, Simon Häberle2*, Dragana Prekajski2*, Hilde De Winter, MD2, Keith M. Dawson, PhD2*, Amélie Croset, PhD2* and Anne Goubier, PhD2*

1Molecular Partners AG, Schlieren-Zurich, Switzerland
2Molecular Partners AG, Zurich-Schlieren, Switzerland

Xiaohui Kong, PhD1,2*, Bixin Wang, MD, PhD1*, Xiwei Wu, PhD, MD3*, Weijia Fu1*, Qinjian Li1*, Moqian Zheng1,2*, Raju Pillai, MD4*, Ryotaro Nakamura, MD5, Paul J. Martin, MD6 and Defu Zeng, MD1,2

1Department of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, Beckman Research Institute of City of Hope, Duarte, CA
2Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA
3Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
4Department of Pathology, City of Hope National Comprehensive Cancer Center, Duarte, CA
5Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
6Fred Hutchinson Cancer Center, Seattle, WA

Qing Xu1,2*, Ya Zhou1,2*, Yuxi Xu, MS2,3*, Rui Wang1,2*, Xiaoqi Wang, MD1,4*, Shijie Yang, PhD1,5*, Qingxiao Song2,6* and Xi Zhang, PhD2,7,8

1Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, China
2Jinfeng Laboratory, Chongqing, China
3Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, AL, China
4Army medical University affiliated Xinqiao Hospital, Chongqing, China
5Army Military Medical University, Chongqing, China
6Xinqiao Hospital of Army Medical University, Chongqing, China
7Affiliated xinqiao Hospital of Army medical University,chongqing ,China, chongqing city, China
8Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China

Ioulia Mavrikou1*, Daniela Taurino2*, Tasoula Touloumenidou3*, Zoi Bousiou, MD4*, Evaggelia-Evdoxia Koravou1*, Anna Vardi, MD4*, Apostolia Papalexandri, MD5*, Christos Demosthenous, MD5*, Maria Koutra1*, Alkistis Kyra Panteliadou, MD5*, Ioannis Batsis1*, Evangelia Yannaki, MD5,6*, Dimitrios Chatzidimitriou7*, Emmanouil Nikolousis, MD, MBBS, PhD, FRCP, FRCPath, MBA8*, Alessandro Rambaldi2*, Ioanna Sakellari, MD, PhD4* and Eleni Gavriilaki, MD, PhD9

1Hematology Department-BMT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
2Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy
3Hematology Department-BMT Unit, Georgios Papanikolaou General Hospital, Thessaloniki, Greece
4Hematology Department – BMT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
5Hematology Department – BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece
6Gene and Cell Therapy Center, Hematology Department-Hematopoietic Cell Transplantation Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
7Microbiology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
8Department of Haematology, American Hospital Dubai UAE, Dubai, United Arab Emirates
9Aristotle University of Thessaloniki, Thessaloniki, Greece

George S. Laszlo, PhD1*, Brenda M. Sandmaier, MD2,3, David J. King, PhD4*, Allie R. Kehret2*, Kyle E. Nyberg2*, Jacob W. Barton2*, Frances M. Cole2*, Junyang Li2*, Margaret C. Lunn-Halbert2*, Donald K. Hamlin5*, D. Scott Wilbur, PhD5*, Johnnie J. Orozco, MD, PhD2,6, Shannon L. Dexter2* and Roland B. Walter, MD, PhD, MS7,8,9

11100 Fairview Avenue North, Fred Hutchinson Cancer Center, Seattle, WA
2Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
3Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA
4Lassen Therapeutics, San Diego, CA
5Department of Radiation Oncology, University of Washington, Seattle, WA
6Department of Medicine/Division of Hematology and Oncology, University of Washington, Seattle, WA
7Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA
8Fred Hutchinson Cancer Center, Seattle, WA
9Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA

Qiao Cheng, PhD1*, Heejin Choi, PhD1*, Yongxia Wu, MD, PhD1, Linlu Tian, PhD1*, Michael Hendrix1* and Xue-Zhong Yu, MD, MSc2

1Department of Microbiology & Immunology; the Cancer Center, Medical College of Wisconsin, Milwaukee, WI
2Department of Microbiology & Immunology; the Cancer Center, Medical College of Wisconsin, Milaukee, WI

*signifies non-member of ASH